Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving transferase
Reexamination Certificate
2000-02-17
2002-10-15
Gitomer, Ralph (Department: 1623)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving transferase
C435S016000, C435S188000
Reexamination Certificate
active
06465202
ABSTRACT:
FIELD OF THE INVENTION
The present invention is directed generally to the field of stabilizing serum or plasma samples. The preferred embodiments include compositions that allow retention of at least 80% of the aminotransferase activities in a serum or plasma sample to be retained 48 hours post collection.
BACKGROUND
Several heart and liver diseases have been correlated with abnormally high levels of serum aspartate aminotransferase (AST). Examples of such conditions include acute myocardial infarction, pulmonary embolism, acute pancreatitis, viral and toxic hepatitis, and acute cirrhosis. Generally speaking, AST is elevated in diseases affecting tissues rich in AST. Similarly, human alanine aminotransferase (ALT) is an enzyme that is leaked into the serum of a patient suffering from hepatic diseases such as viral hepatitis, hepatocirrhosis, etc., and is important as a clinical marker.
Serodiagnosis of ALT and AST is a good indicator of whether a particular subject is undergoing distress in a diseased state. More particularly, the presence of elevated AST or ALT is a good indicator of liver disease. The assays for determining the activity of these enzymes generally involve extracting blood from the subject and immediately employing one of a number of calorimetric or kinetic ultraviolet techniques. Such techniques are described in for example U.S. Pat. Nos. 5,834,226, 5,952,211, and 4,769,323, which describe various assays for aminotransferase activity. A particularly well characterized assay for AST and ALT is that sold by Sigma Chemical Company as part of the aspartate aminotransferase (AST/GOT) test kits.
Regardless of the assay format employed to determine aminotransferase activity, it has been common practice to use these assays on venous blood drawn from the patient in a clinical setting. The assays are performed on serum separated from the whole blood drawn from the patient. This is due to the fact that the aminotransferase activity from red blood cells is sufficiently high to mask the activity present in the serum from other organs. Thus, it is preferable to remove the red blood cells from whole blood in order to obtain an accurate reading of the levels of aminotransferase activity attributable to origins other than the red blood cells.
In addition, aminotransferase enzyme activity in the serum is relatively unstable as a function of time, and, for this reason, it has been common practice to analyze serum relatively quickly once the serum is separated from whole blood. This practice has meant that serodiagnosis for indications of disorders in which the aminotransferase activities are elevated have been performed in the clinical setting as opposed to a setting distant from the hospital.
BRIEF SUMMARY
A need presently exists for a method and system for serodiagnostic purposes, where the sample is stable and retains aminotransferase activity over an extended period of time post collection without the need for additional conditions, such as freeze drying or refrigeration. Such a method would facilitate collection of a sample of blood at a location remote from the location at which analysis is performed. For example, such a method would allow for a patient to collect a sample of blood at home and mail it to diagnostic laboratory for testing.
The preferred method and system described below stabilize blood plasma by separating plasma from whole blood and contacting the plasma with a stabilizing composition. This stabilizing composition is effective to retain an amino transferase activity in the plasma at an activity of at least about 80 percent of initial activity, 48 hours post-collection at a temperature of about 25°C. The presently preferred stabilizing composition comprises between about 20 mM to about 1 M EDTA and between about 1 mM and about 1 M citrate, when the composition is in solution.
The foregoing paragraphs have been provided by way of introduction, and they are not intended to limit the scope of the following claims.
REFERENCES:
patent: 3640267 (1972-02-01), Hurtig et al.
patent: 4990457 (1991-02-01), Tanaka et al.
patent: 5059525 (1991-10-01), Bartl et al.
patent: 5147803 (1992-09-01), Enomoto
patent: 5244788 (1993-09-01), Hubscher
patent: 5558834 (1996-09-01), Chu et al.
patent: 5788942 (1998-08-01), Kitani et al.
patent: 5807358 (1998-09-01), Herweck et al.
patent: 5824268 (1998-10-01), Bernstein et al.
patent: 5834226 (1998-11-01), Maupin
patent: 5860929 (1999-01-01), Rubin et al.
patent: PL 146644 (1989-02-01), None
patent: WO 79/01131 (1979-05-01), None
Gowenlock A. Varleys's Practical Clinical Biochemistry 6th ed., CRC Press, Boca Raton, FL, 1990.*
Breuer Von J. Enzyme Activites in Serum and Plasma . . . Z Klin Chem Klin Biochem 13(8)355-360, 1975.*
Abstract, “The effect of operating and formulation variables on the morphology of spray-dried protein particles.”, Maa YF, et al.,Pharm Dev Technol1997 Aug.; 2(3):213-23.
Abstract, “Determination of vitamin A in dried human blood spots by high-performance capillary electrophoresis with laser-excited fluorescence detection.”, Shi H, et al.,J Chromatogr B Biomed Appl1995 Mar. 10; 665(1):89-96.
Abstract, “Characterization of differentiated Syrian golden hamster pancreatic duct cells maintained in extended monolayer culture.”, Hubchak S, et al.,In Vitro Cell Dev Biol1990 Sep.; 26(9):889-97.
BioSafe Laboratories, Inc.
Gitomer Ralph
Olson & Hierl Ltd.
LandOfFree
Method for stabilizing aminotransferase activity in a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for stabilizing aminotransferase activity in a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for stabilizing aminotransferase activity in a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2991218